Display options
Cite
Henderson R, Reilly DA, Cooper JS. Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues. Plast Reconstr Surg Glob Open. 2018;6(1):e1618doi: 10.1097/GOX.0000000000001618.
Henderson, R., Reilly, D. A., & Cooper, J. S. (2018). Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues. Plastic and reconstructive surgery. Global open, 6(1), e1618. https://doi.org/10.1097/GOX.0000000000001618
Henderson, Raven, et al. "Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues." Plastic and reconstructive surgery. Global open vol. 6,1 (2018): e1618. doi: https://doi.org/10.1097/GOX.0000000000001618
Henderson R, Reilly DA, Cooper JS. Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues. Plast Reconstr Surg Glob Open. 2018 Jan 11;6(1):e1618. doi: 10.1097/GOX.0000000000001618. eCollection 2018 Jan. PMID: 29464158; PMCID: PMC5811288.
Copy Download .nbib Format: NLM
Share it on

Plast Reconstr Surg Glob Open. 2018 Jan 11;6(1):e1618. doi: 10.1097/GOX.0000000000001618. eCollection 2018 Jan.

Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues.

Plastic and reconstructive surgery. Global open

Raven Henderson, Debra A Reilly, Jeffrey S Cooper

Affiliations

  1. Division of Plastic & Reconstructive Surgery, University of Nebraska Medical Center, Omaha, Neb.; and Department of Emergency Medicine, University of Nebraska Medical Center, Omaha, Neb.

PMID: 29464158 PMCID: PMC5811288 DOI: 10.1097/GOX.0000000000001618

Abstract

Natural and synthetic fillers have revolutionized aesthetic facial rejuvenation and soft-tissue augmentation. We present a case highlighting the dangers of filler self-injection. A 37-year-old woman self-injected a dermal filler around both temples. She immediately experienced left--side hearing loss, blanching over the left face, and pain. Prompt treatment with hyaluronidase, topical nitro paste, and warm compresses ensued. An emergency computed tomography angiogram showed occlusion of a superficial temporal artery branch. We treated her with enoxaparin, aspirin, dexamethasone, piperacillin-tazobactam, and intradermal lidocaine. After 6 hyperbaric oxygen therapy (HBO2) treatments in 3 days, the patient showed improvement in appearance with markedly decreased ischemic discoloration and her hearing returned to baseline. Algorithms for treating such injuries generally neglect HBO2. HBO2 is thought to be efficacious in these situations by a variety of mechanisms: oxygenation of ischemic tissues, reduction of edema, amelioration of ischemic/reperfusion injury, promotion of angiogenesis and collagen maturation. Her resolved hearing highlights the utility of HBO2 in sudden hearing loss as well. Injectors should have guidelines for using product, not only on patients but staff as well. Filler courses should include handling complications and include HBO2 in their guidelines. Clinicians should remind patients to seek treatment from qualified clinicians. The goal of a bargain price using self-injection may quickly become expensive and disfiguring.

References

  1. Clin Cosmet Investig Dermatol. 2013 Dec 12;6:295-316 - PubMed
  2. Aesthet Surg J. 2010 May-Jun;30(3):442-5 - PubMed
  3. Dermatol Surg. 2007 Mar;33(3):357-60 - PubMed
  4. Dermatol Surg. 2006 Feb;32(2):276-81 - PubMed
  5. Am J Clin Dermatol. 2015 Aug;16(4):271-283 - PubMed
  6. Dermatol Surg. 2014 Sep;40(9):1049-52 - PubMed
  7. Cochrane Database Syst Rev. 2012 Oct 17;10:CD004739 - PubMed
  8. Plast Reconstr Surg. 2011 Jan;127 Suppl 1:131S-141S - PubMed
  9. Eur J Vasc Surg. 1991 Dec;5(6):677-9 - PubMed

Publication Types